SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glaxosmithkline Pharmaceuticals reports consolidated net loss of Rs 661 crore in Q3

04 Feb 2020 Evaluate

Glaxosmithkline Pharmaceuticals has reported results for third quarter ended December 31, 2019.

The company has reported a net loss of Rs 644.14 crore for the quarter under review against net profit of Rs 112.97 crore for the same quarter in the previous year. Total income of the company decreased by 5.56% at Rs 794.93 crore for Q3FY20 as compared Rs 841.77 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a net loss of Rs 661.16 crore for the quarter under review against net profit of  Rs 113.67 crore for the same quarter in the previous year. Total income of the company decreased by 5.56% at Rs 795.09 crore for Q3FY20 as compared Rs 841.93 crore for the corresponding quarter previous year.

Glaxosmithkline Phar Share Price

2451.80 32.70 (1.35%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×